Recombinant Rv1654 protein of Mycobacterium tuberculosis induces mitochondria‐mediated apoptosis in macrophage

Kang‐In Lee,Seunga Choi,Han‐Gyu Choi,Sintayehu Kebede Gurmessa,Thi Binh Dang,Yong Woo Back,Hye‐Soo Park,Hwa‐Jung Kim
DOI: https://doi.org/10.1111/1348-0421.12880
2021-03-24
Microbiology and Immunology
Abstract:Mycobacterium tuberculosis contains diverse immunologically active components. In this study, we investigated the biological function of a newly identified component, Rv1654, with potential to induce apoptosis in macrophages. Recombinant Rv1654 induced macrophage apoptosis in a caspase‐9/3‐dependent manner through reactive oxygen species (ROS) production and interaction with Toll‐like receptor 4. In addition, Rv1654 induced tumor necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6), and monocyte chemoattractant protein‐1 (MCP‐1) production through the mitogen‐activated protein kinase pathway. Furthermore, Rv1654‐induced c‐Jun N‐terminal kinase (JNK) activation was inhibited by the ROS scavenger and Rv1654‐induced apoptosis was inhibited by the JNK inhibitor. Moreover, we found that treatment of macrophages with Rv1654 led to loss of mitochondrial membrane potential, release of cytochrome c into the cytosol, and translocation of Bax into the mitochondria. Finally, Rv1654‐mediated apoptosis was inhibited in macrophages transfected with Bax siRNA. These results suggest that Rv1654 induces macrophage apoptosis through a mitochondrial‐dependent pathway and ROS‐mediated JNK activation.This article is protected by copyright. All rights reserved.
immunology,microbiology
What problem does this paper attempt to address?